Accessing US Markets - Soft Landings - Invite Only

15 September

Kindly hosted by the BioMelbourne Network, Dr Rosen's first session on Monday, 27th September will be to address an industry specific group on Translational Research in Bioengineering - the Boston University Experience; and Accessing US Markets - Soft Landings and the Role of Incubators.

The translational research path in the area of medical devices and bioengineering is a unique one and Dr Jonathan Rosen knows it well. Before becoming executive director of the Institute for Technology Entrepreneurship & Commercialisation (ITEC) at Boston University he was the director of the CIMIT Office of Technology Implementation, where he helped establish collaborative research teams and supported translational research programs in biomaterials, tissue engineering, optical diagnostics, orthopedics, trauma and critical care.

The aim was to work with scientists, licensing offices and the investment community to design and implement new models for improving patient care by partnering innovative new medical technologies with product development environments.

Today, he serves as Special Assistant to the Provost at Boston University, continues as senior advisor to the CIMIT Consortium, develops medical technologies for global health, and is a founding board member of the Institute for Paediatric Innovation. Before this Dr. Rosen spent considerable time in developing advanced medical technologies for cardiovascular, neurosurgical, and spinal surgery. He served as Chief Technology Officer for the Codman & Surtleff Surgical Division of Johnson & Johnson. His entrepreneurial experience includes the founding of medical technology companies in the US and internationally. Dr Rosen received his PhD in Biomaterials and Bioengineering from Case Western Reserve University and his MBA in Strategic Planning from Columbia University.

What's On

June

S M T W T F S
 
 
 
 
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 

What people say about veski

“Our research program is focused on working with industrial partners to develop novel therapeutics that will transform the treatment of chronic inflammatory diseases such as IBD.”

- Professor Colby Zaph

Tweets from @veskiorg